Genetics of the thrombomodulin-endothelial cell protein C receptor system and the risk of early-onset ischemic stroke
- PMID: 30383853
- PMCID: PMC6211695
- DOI: 10.1371/journal.pone.0206554
Genetics of the thrombomodulin-endothelial cell protein C receptor system and the risk of early-onset ischemic stroke
Abstract
Background and purpose: Polymorphisms in coagulation genes have been associated with early-onset ischemic stroke. Here we pursue an a priori hypothesis that genetic variation in the endothelial-based receptors of the thrombomodulin-protein C system (THBD and PROCR) may similarly be associated with early-onset ischemic stroke. We explored this hypothesis utilizing a multi-stage design of discovery and replication.
Methods: Discovery was performed in the Genetics-of-Early-Onset Stroke (GEOS) Study, a biracial population-based case-control study of ischemic stroke among men and women aged 15-49 including 829 cases of first ischemic stroke (42.2% African-American) and 850 age-comparable stroke-free controls (38.1% African-American). Twenty-four single-nucleotide-polymorphisms (SNPs) in THBD and 22 SNPs in PROCR were evaluated. Following LD pruning (r2≥0.8), we advanced uncorrelated SNPs forward for association analyses. Associated SNPs were evaluated for replication in an early-onset ischemic stroke population (onset-age<60 years) consisting of 3676 cases and 21118 non-stroke controls from 6 case-control studies. Lastly, we determined if the replicated SNPs also associated with older-onset ischemic stroke in the METASTROKE data-base.
Results: Among GEOS Caucasians, PROCR rs9574, which was in strong LD with 8 other SNPs, and one additional independent SNP rs2069951, were significantly associated with ischemic stroke (rs9574, OR = 1.33, p = 0.003; rs2069951, OR = 1.80, p = 0.006) using an additive-model adjusting for age, gender and population-structure. Adjusting for risk factors did not change the associations; however, associations were strengthened among those without risk factors. PROCR rs9574 also associated with early-onset ischemic stroke in the replication sample (OR = 1.08, p = 0.015), but not older-onset stroke. There were no PROCR associations in African-Americans, nor were there any THBD associations in either ethnicity.
Conclusion: PROCR polymorphisms are associated with early-onset ischemic stroke in Caucasians.
Conflict of interest statement
Drs. Cole, Mitchell, Kittner, Longstreth, and Worrall are supported by research grants from National Institutes of Health (NIH). Dr Cole is supported by a research grants from the American Heart Association and Bayer Pharmaceuticals. Dr. Worrall is Deputy Editor for AAN/Neurology. Dr. Boncoraglio is supported by a research grant from the Fondazione IRCCS Istituto Neurologico Carlo Besta. Dr. Metso is supported by grants from the Finnish Medical Foundation, the Orion Farmos Research Foundation, the Maud Kuistila Memorial Foundation, and the Emil Aaltonen Foundation. Dr. Danesh serves on advisory boards for Novartis, Merck Sharp & Dohme UK, Sanofi, the Medical Research Council, and Wellcome Trust and is a consultant for Takeda. These do not alter the authors adherence to PLOS ONE policies on sharing data and materials. The other authors report no disclosures.
Figures
References
-
- Esmon CT, Owen WG. Identification of an endothelial cell cofactor for thrombin-catalyzed activation of Protein C. Proc Natl Acad Sci USA. 1981;78:2249–52. https://www.ncbi.nlm.nih.gov/pubmed/?term=7017729 - PMC - PubMed
-
- Esmon CT. Thrombomodulin as a model of molecular mechanism that modulates protease specificity and function at the vessel surface. FASEB J. 1995;9:946–55. https://www.ncbi.nlm.nih.gov/pubmed/?term=7615164 - PubMed
-
- Esmon CT. The regulation of natural anticoagulant pathways. Science. 1987;235:1348–52. https://www.ncbi.nlm.nih.gov/pubmed/?term=3029867 - PubMed
-
- Barnes PJ, Karin M. Nuclear factor-kappa b: a pivotal transcription factor in chronic inflammatory disease. N Engl J Med. 1997;336:1066–71. 10.1056/NEJM199704103361506 https://www.ncbi.nlm.nih.gov/pubmed/?term=9091804 - DOI - PubMed
-
- Esmon CT. Role of coagulation inhibitors in inflammation. Thromb Haemost. 2001;86:51–6. https://www.ncbi.nlm.nih.gov/pubmed/?term=11487041 - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
- U01 HG005160/HG/NHGRI NIH HHS/United States
- R01 HL087676/HL/NHLBI NIH HHS/United States
- WT084724MA/WT_/Wellcome Trust/United Kingdom
- Z01 AG000954/AG/NIA NIH HHS/United States
- U01 HG004424/HG/NHGRI NIH HHS/United States
- HHSN268200782096C/HG/NHGRI NIH HHS/United States
- R01 NS039987/NS/NINDS NIH HHS/United States
- FS/14/55/30806/BHF_/British Heart Foundation/United Kingdom
- U01 HG005157/HG/NHGRI NIH HHS/United States
- U01 HG005152/HG/NHGRI NIH HHS/United States
- U54 RR020278/RR/NCRR NIH HHS/United States
- R01 NS045012/NS/NINDS NIH HHS/United States
- R01 NS017950/NS/NINDS NIH HHS/United States
- R01 NS042733/NS/NINDS NIH HHS/United States
- RG/13/13/30194/BHF_/British Heart Foundation/United Kingdom
- U01 HG004446/HG/NHGRI NIH HHS/United States
- R01 AG054076/AG/NIA NIH HHS/United States
- Z01 AG000954/ImNIH/Intramural NIH HHS/United States
- 085475/B/08/Z/WT_/Wellcome Trust/United Kingdom
- T32 AG000262/AG/NIA NIH HHS/United States
- MR/L003120/1/MRC_/Medical Research Council/United Kingdom
- R01 NS100178/NS/NINDS NIH HHS/United States
- P30 DK072488/DK/NIDDK NIH HHS/United States
- U01 NS069208/NS/NINDS NIH HHS/United States
- 090532/Z/09/Z/WT_/Wellcome Trust/United Kingdom
- R01 NS034447/NS/NINDS NIH HHS/United States
- U01 HG004436/HG/NHGRI NIH HHS/United States
- R01 NS105150/NS/NINDS NIH HHS/United States
- WT_/Wellcome Trust/United Kingdom
- P30 AG010129/AG/NIA NIH HHS/United States
- Z01 AG000015/ImNIH/Intramural NIH HHS/United States
- U01 AG049505/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous